Loading stock data…
Streamex Corp. (STEX)
$0.80+0.00 (+0.16%)
After Hours$0.80+0.00 (+0.00%)· Last close Jun 29
Streamex Corp., a medical device technology company, provides advanced digital signal processing solutions for electrophysiology in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Streamex Corp. in the Financial Services sector is trading at $0.80 with a market capitalization of $322M. Wall Street consensus targets $8.00 (1 analysts), implying a +896.9% move over the next 12 months. The stock is currently near its 52-week low of $0.70, remaining 72.7% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +896.9% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 31) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$35.75M↑ | -$41.63M↓ | -$6.11M↑ | -$20.36M↓ | -$2.98M |
| Net Income | -$46.69M↑ | -$424.01M↓ | -$15.58M↑ | -$20.37M↓ | -$2.81M |
Peer Comparison
JPMBACGS
Fundamentals
Streamex Corp., a medical device technology company, provides advanced digital signal processing solutions for electrophysiology in the United States. The company offers the PURE EP platform, which delivers cardiac signal data to electrophysiologists...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$322.15M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-318.47%
Volume
Today's trading volume
1.00M
Recent News
Streamex (NasdaqCM:STEX) Stock Fair Value Falls As GLDY Rollout Concerns Temper Partnership Optimism
Analysts have revised their fair value estimate for Streamex from US$12 to US$8. Recent commentary links this change to slower than hoped GLDY traction and a mixed read through from new partnership announcements, which has led analysts to recalibrate how quickly the company’s roadmap might translate into financial results. Read on to see how this updated price target fits into the evolving Streamex story and how you can track future changes in the narrative. Analyst Price Targets don't always...
3 Growth Companies With High Insider Ownership And Up To 114% Earnings Growth
The United States market has shown robust performance, climbing 1.6% in the last 7 days and up 28% over the past year, with earnings forecasted to grow by 17% annually. In this thriving environment, growth companies with high insider ownership can be particularly appealing as they often signal strong confidence from those closest to the business and can offer significant potential for earnings growth.
Streamex Corp (STEX) Q1 2026 Earnings Call Highlights: A Milestone Quarter with New Product ...
Streamex Corp (STEX) celebrates the launch of GLDY and zero debt status, while navigating revenue challenges and operational hurdles.
Biosig Technologies Q1 Earnings Call Highlights
Biosig Technologies (NASDAQ:STEX), operating as Streamex Corp, said its first quarter of 2026 marked a transition from product preparation to early commercialization, highlighted by the launch of its tokenized gold product, the payment of initial dividends to holders and the retirement of its conver
Exclusive: Streamex CEO explains gold-leasing model behind GLDY
Investing.com -- Streamex Corp. shares have jumped more than 15% on Tuesday, but the single-day gain comes against a difficult backdrop, with the stock down 64.8% year-to-date. It has also lost 60.9% over the past 12 months.